Unjha Formulations Surges to 52-Week High, Outperforming Sector and MarketsMOJO Gives 'Hold' Rating

Unjha Formulations, a microcap pharmaceutical company, has recently seen a surge in its stock price, reaching a 52-week high on May 22, 2024. The stock has been performing well in the market, with MarketsMOJO giving it a 'Hold' rating.

On May 22, the stock hit a high of Rs.33.4, outperforming the sector by 4.15%. It has also shown consecutive gains for the past two days, with a return of 9.94% during this period. The stock opened with a gain of 4.52% today and reached an intraday high of Rs.33.4, a 4.77% increase.

Unjha Formulations is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market. In the past year, the company's stock has shown a remarkable performance of 139.24%, while the Sensex has only seen a 19.59% increase.

Unjha Formulations is a microcap company in the pharmaceutical industry, and its recent stock performance reflects its strong position in the market. With a 'Hold' rating from MarketsMOJO, investors may want to keep an eye on this company as it continues to make strides in the industry.